Dienstag, August 2, 2022
StartBiotechnologyNew patent for Cubist Pharms drug ZERBAXA – DrugPatentWatch

New patent for Cubist Pharms drug ZERBAXA – DrugPatentWatch


Copyright © DrugPatentWatch. Initially revealed at New patent for Cubist Pharms drug ZERBAXA

Annual Drug Patent Expirations for ZERBAXA
Annual Drug Patent Expirations for ZERBAXA

Zerbaxa is a drug marketed by Cubist Pharms Llc and is included in a single NDA. It’s obtainable from one provider. There are 13 patents defending this drug.

This drug has eigthy-six patent relations in thirty-one nations.

The generic ingredient in ZERBAXA is ceftolozane sulfate; tazobactam sodium. One provider is listed for this compound. Further particulars can be found on the ceftolozane sulfate; tazobactam sodium profile web page.

For extra info on how DrugPatentWatch may help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com

Make Higher Selections with DrugPatentWatch

» Begin Your Free Trial In the present day «

Copyright © DrugPatentWatch. Initially revealed at New patent for Cubist Pharms drug ZERBAXA

RELATED ARTICLES

Most Popular

How Is Half Of Nato

How Is Half Of Pc

How Is Msw Course

How Is It

Recent Comments